CNS Pharmaceuticals Q3 EPS $(0.25) Misses $(0.12) Estimate

CNS Pharmaceuticals -1.26%

CNS Pharmaceuticals

CNSP

0.10

-1.26%

CNS Pharmaceuticals (NASDAQ:CNSP) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.12) by 108.33 percent. This is a 99.54 percent increase over losses of $(54.14) per share from the same period last year.

Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via